<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">Severe cases are the most challenging as they may be complicated by a severe Acute Respiratory Distress Syndrome (ARDS) 
 <xref rid="b0010" ref-type="bibr">[2]</xref>. The current management of ARDS is only supportive 
 <xref rid="b0015" ref-type="bibr">[3]</xref>. But there are many ongoing clinical trials testing potential antiviral drugs that have been used against Betacoronaviruses associated with previous epidemics of SARS-CoV and MERS-Cov (HIV drugs or Ebola frizzled drug) as well as promising malaria drugs chloroquine and hydroxychloroquine.
</p>
